InsidersTradesSigma
Browse the complete record of transactions filed by BALDO LANCE, Directeur Médical. Officer active across 1 companies, notably Adaptive Biotechnologies Corp. In total, 2 filings have been published. Total volume traded: €61k. The latest transaction was filed on 8 March 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Lance Baldo is the Chief Medical Officer at Adaptive Biotechnologies Corp. He oversees the company's medical and research initiatives, ensuring that products meet quality standards. Lance plays a key role in developing new health solutions.